#AI-powered #drugdiscovery company #IambicTherapeutics has announced the terms of its #Nasdaq #IPO, pitching at a valuation of more than $800 million if all goes through as planned.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#AI-powered #drugdiscovery company #IambicTherapeutics has announced the terms of its #Nasdaq #IPO, pitching at a valuation of more than $800 million if all goes through as planned.
@nile11.bsky.socialUltra Raises $62M to Deploy Warehouse Robots Without Humanoids
..................
https://nile1.com/ultra-raises-62m-to-deploy-warehouse-robots-without-humanoids/
..................
#arenaAi #atoms #exotec #frameworkVentures #humanoidRobots #iambicTherapeutics #jonMillerSchwartz #non-humanoidRobots
@pharmaphorum.bsky.social#IambicTherapeutics, which specialises in applying #AI to #drugdiscovery and development, has filed for an #IPO on the #Nasdaq, shortly after adding #AbbVie to its roster of #pharma partners and launching the latest version of its #Enchant platform.
@thedailyfathom.bsky.socialBIOTECH · AI drug startup Iambic files for IPO, signs AbbVie deal
The Nvidia-backed biotech had a big Monday: an IPO filing and a new AI partnership with AbbVie.